Ecolab Life Sciences opens Bioprocessing Applications Lab in Korea to support downstream process development across Asia.
Article excerpt
Highlighted: the sentence this signal was extracted from
Ecolab Life Sciences opens Bioprocessing Applications Lab in Korea to support downstream process development across Asia. New facility serves biopharma manufacturers throughout the region with local access to customer purification studies across Ecolab's Purolite resin portfolio. Ecolab Life Sciences is expanding the bioprocessing business with the launch of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, giving biopharmaceutical manufacturers across Asia better local access to downstream process development support. Strategically located to serve customers throughout the region, the site is Ecolab's first bioprocessing facility in Asia and joins an established applications network in the United States and the United Kingdom. BPAL Korea supports process development from early-stage resin screening through studies designed to replicate commercial manufacturing conditions. On-site scientists work alongside customers across Asia to help optimize chromatography steps, improve yield and productivity, and accelerate regulatory pathways, reducing the need to ship resins and reference materials overseas for development work. Asia has become one of the world's most active biopharmaceutical manufacturing regions, with Korea, China, Japan, India, and Singapore all home to growing pipelines in biosimilars and monoclonal antibody processes that demand efficient...
Keep reading with a free account
The rest of this article, and every signal for Ecolab, is in your free account.
